These results suggest a favorable trend in CV outcomes consistent with studies of injectable semaglutides.
← all excerpts
Oral Glucagon-Like Peptide-1 Receptor Agonists for Preventing Cardiorenal Complications.
1
—
—
These results suggest a favorable trend in CV outcomes consistent with studies of injectable semaglutides.